BioRender

Toronto, Canada

BioRender develops a science visualization platform for the pharmaceutical and life sciences industries.

$15.3M raised

Apr 2023

Series A

Top Investors

Y CombinatorLiquid 2 VenturesFundersClubRefactorBrad Flora

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has BioRender raised?

BioRender has raised $15.3M in total funding. The most recent round was Series A. The last funding was announced in April 2023.

Who are BioRender's investors?

BioRender's investors include Y Combinator, Liquid 2 Ventures, FundersClub, Refactor, Brad Flora.

Where is BioRender headquartered?

BioRender is headquartered in Toronto, Canada.

What does BioRender do?

BioRender develops a science visualization platform for the pharmaceutical and life sciences industries.

What stage is BioRender at?

BioRender is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 20, 2023.

MLA

"BioRender — Funding & Investors." VCBacked, April 20, 2023, https://www.vcbacked.co/company/biorender. Accessed June 4, 2026.

APA

VCBacked. (2023). BioRender — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/biorender

Wikipedia (cite web)

{{cite web |title=BioRender — Funding & Investors |url=https://www.vcbacked.co/company/biorender |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 20, 2023.